Switzerland’s flu drug stockpile sufficient
October 19th, 2006
Swiss authorities have announced that the country’s flu drugs provisions should be sufficient in the event of a pandemic. The government has placed an order of 8 million doses of a pre-pandemic vaccine produced by the Anglo-American company GlaxoSmithKline. The cost of the operation is estimated to be around 142 million USD. Stockpiling will commence in January of next year. The vaccination will be voluntary, but the amount of doses is expected to be enough for the immunization of the whole population of 7.4 million.